Benralizumab Reduces Respiratory Exacerbations and Oral Glucocorticosteroid Dose in Patients with Severe Asthma and Eosinophilic Granulomatosis with Polyangiitis
Journal of Asthma and Allergy(2024)
Key words
EGPA,asthma,CRS,vasculitis,glucocorticoid,OCS,anti-IL5R,biologics,benralizumab
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined